Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
BMJ Open|February 24, 2024
Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, CanadaKristen A Morin, Mark Tatangelo, David Marsh
Frontiers in Psychiatry|January 6, 2022
Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, CanadaKristen A Morin, Frank Vojtesek, Shreedhar Acharya, et al.
Substance Abuse Treatment, Prevention, and Policy|September 21, 2016
Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic'Joseph K Eibl, Kristen A Morin-Taus, David C Marsh
BMC Health Services Research|April 13, 2022
Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care frameworkFarah Tahsin, Kristen A Morin, Frank Vojtesek, et al.
The International Journal on Drug Policy|January 1, 2021
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, CanadaKristen A Morin, Shreedhar Acharya, Joseph K Eibl, et al.
European Journal of Epidemiology|January 27, 2025
Cohort profile: the provincial opioid agonist treatment cohort in Ontario, CanadaKristen A Morin, Mark R Tatangelo, Shreedhar Acharya, et al.
BMC Health Services Research|December 7, 2023
Evaluating an addiction medicine unit in Sudbury, Ontario Canada: a mixed-methods study protocolKristen A Morin, Karla Ghartey, Adele Bodson, et al.
Pageof 3